Aliskiren Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double-Blind Placebo-Controlled Trial

BACKGROUND: The renin–angiotensin system is well recognized as a mediator of pathophysiological events in atherosclerosis. The benefits of renin inhibition in atherosclerosis, especially when used in combination with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs)...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mihai, Georgeta, Varghese, Juliet, Kampfrath, Thomas, Gushchina, Liubov, Hafer, Lisa, Deiuliis, Jeffrey, Maiseyeu, Andrei, Simonetti, Orlando P., Lu, Bo, Rajagopalan, Sanjay
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2013
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3698800/
https://ncbi.nlm.nih.gov/pubmed/23686372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.112.004879
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky